Clinical Trial Update: Trial to Compare BCG-Bulgaria and BCG-Denmark [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing BCG-Bulgaria vs BCG-Denmark with focus on neonatal and infant mortality and morbidity outcomes; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Morbidity
• Infant Mortality
• Neonatal Mortality
• Newborn Morbidity

Drugs mentioned

• BCG-Bulgaria (Bacillus Calmette-Guérin)
• BCG-Denmark (Bacillus Calmette-Guérin)

Snippet

Sponsor: Bandim Health Project | Conditions: Death; Neonatal, Death, Infant | Phase 4 | Status: UNKNOWN